The matter was reported by a customer complaint.
Presence of glass particulate in an intravenous drug presents a risk for thromboembolism, mechanical blocking of capillaries or arterioles and tissue inflammation. Patients with preexisting conditions of trauma or other conditions that affect the microvascular blood supply are at an increased risk for an adverse event.
No adverse events have yet been reported in association with this issue.
More Articles on Recalls:
Hospira Recalls Propofol Injectable Emulsion, USP
Covidien Recalls Pipeline Embolization Device, Alligator Retrieval Device
What the Increase in Device Recalls Means for Hospitals
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
